Quantitation of Simulated Short Echo Time 1H Human Brain Spectra by LCModel and AMARES

Magnetic Resonance in Medicine

Volumn 51, Issue 5, 2004, Pages 904-912

  Kanowski, Martin ^a   Kaufmann, Jörn ^a   Braun, Jürgen ^b   Bernarding, Johannes ^b   Tempelmann, Claus ^a  

^a OTTO VON GUERICKE UNIVERSITY   (Germany)

^b FREIE UNIVERSITÄT BERLIN   (Germany)

Author keywords

AMARES; Brain; LCModel; Magnetic resonance spectroscopy; Quantitation; Short echo time

Indexed keywords

AMINO ACIDS; BRAIN; MAGNETIC RESONANCE; MAGNETIC RESONANCE SPECTROSCOPY; METABOLITES;

ACCURACY AND PRECISION; AMARES; ECHO TIME; LCMODEL; MAGNETIC RESONANCE SPECTROSCOPIES (MRS); QUANTITATION; SIGNAL CONTRIBUTION; SIMULATED SPECTRA;

SIGNAL TO NOISE RATIO;

CREATINE; GLUTAMIC ACID;

ACCURACY; ARTICLE; BRAIN METABOLISM; COMPUTER PROGRAM; IMAGE ANALYSIS; IN VIVO STUDY; INFORMATION PROCESSING; INTERMETHOD COMPARISON; MACROMOLECULE; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PROTON NUCLEAR MAGNETIC RESONANCE; QUANTITATIVE ANALYSIS; SIGNAL NOISE RATIO; SIMULATION;

EID: 2342467439     PISSN: 07403194     EISSN: None     Source Type: Journal    
DOI: 10.1002/mrm.20063     Document Type: Article

References (25)

1. Slotboom J, Boesch C, Kreis R. Versatile frequency domain fitting using time domain models and prior knowledge. Magn Reson Med 1998;39: 899-911.
2. Soher BJ, Young K, Govindaraju V, Maudsley AA. Automated spectral analysis III: application to in vivo proton MR spectroscopy and spectroscopic imaging. Magn Reson Med 1998;40:822-831.
3. Bartha R, Drost DJ, Williamson PC. Factors affecting the quantification of short echo in-vivo 1H MR spectra: prior knowledge, peak elimination, and filtering. NMR Biomed 1999;12:205-216.
4. Provencher SW. Estimation of metabolite concentrations from localized in vivo proton NMR spectra. Magn Reson Med 1993;30:672-679.
5. http://carbon.uab.es/mrui
6. http://s-provencher.com/pages/lcmodel.shtml
7. Vanhamme L, van den Boogaart A, Van Huffel S. Improved method for accurate and efficient quantification of MRS data with use of prior knowledge. J Magn Reson 1997;129:35-43.
8. Behar KL, Rothman DL, Spencer DD, Petroff OA. Analysis of macromolecule resonances in 1H NMR spectra of human brain. Magn Reson Med 1994;32:294-302.
9. Hofmann L, Slotboom J, Boesch C, Kreis R. Characterization of the macromolecule baseline in localized 1H-MR spectra of human brain. Magn Reson Med 2001;46:855-863.
10. Saunders DE, Howe FA, van den Boogaart A, Griffiths JR, Brown MM. Discrimination of metabolite from lipid and macromolecule resonances in cerebral infarction in humans using short echo proton spectroscopy. J Magn Reson Imaging 1997;7:1116-1121.
11. Hofmann L, Slotboom J, Jung B, Maloca P, Boesch C, Kreis R. Quantitative 1H-magnetic resonance spectroscopy of human brain: influence of composition and parameterization of the basis set in linear combination model-fitting. Magn Reson Med 2002;48:440-453.
12. Seeger U, Klose U, Mader I, Grodd W, Nägele T. Parameterized evaluation of macromolecules and lipids in proton MR spectroscopy of brain diseases. Magn Reson Med 2003;49:19-28.
13. Seeger U, Mader I, Nägele T, Grodd W, Lutz O, Klose U. Reliable detection of macromolecules in single-volume 1H NMR spectra of the human brain. Magn Reson Med 2001;45:948-954.
14. 1H NMR spectra of the rat brain. J Magn Reson 1999;141:104-120.
15. Auer DP, Gössl C, Schirmer T, Czisch M. Improved analysis of 1H-MR spectra in the presence of mobile lipids. Magn Reson Med 2001;46: 615-618.
16. Klose U. In vivo proton spectroscopy in presence of eddy currents. Magn Reson Med 1990;14:26-30.
17. Marshall I, Bruce SD, Higinbotham J, MacLullich A, Wardlaw JM, Ferguson KJ, Seckl J. Choice of spectroscopic lineshape model affects metabolite peak areas and area ratios. Magn Reson Med 2000;44:646-469.
18. Knijn A, de Beer R, van Ormondt D. Frequency-selective quantification in the time domain. J Magn Reson 1992;97:444-450.
19. Marshall I, Higinbotham J, Bruce S, Freise A. Use of Voigt lineshape for quantification of in vivo 1H spectra. Magn Reson Med 1997;37:651-657.
20. Schirmer T, Auer DP. On the reliability of quantitative clinical magnetic resonance spectroscopy of the human brain. NMR Biomed 2000; 13:28-36.
21. Soher BJ, Young K, Maudsley AA. Representation of strong baseline contributions in 1H MR spectra. Magn Reson Med 2001;45:966-972.
22. Helms G. Analysis of 1.5 Tesla proton MR spectra of human brain using LCModel and an imported basis set. Magn Reson Imaging 1999;17: 1211-1218.
23. Mierisová Š, van den Boogaart A, Tkáč I, Van Hecke P, Vanhamme L, Liptaj T. New approach for quantitation of short echo time in vivo 1H MR spectra of brain using AMARES. NMR Biomed 1998;11:32-39.
24. Stanley JA, Drost DJ, Williamson PC, Thompson RT. The use of a priori knowledge to quantify short echo in vivo 1H MR spectra. Magn Reson Med 1995;34:17-24.
25. Kreis R, Boesch C. Bad spectra can be better than good spectra. In: Proceedings of the 11th Annual Meeting of ISMRM, Toronto, Canada, 2003. p 264.